End-Stage Renal Disease is a life-changing disease for employees and a catastrophic health plan expense for employers, so plan sponsors need their insurance carriers to help employees stay healthy in order to control costs, as well as coordinate with Medicare.
Increasing transparency and lowering the cost of prescription drugs has long been a point of discussion in Congress, medical offices, and dining room tables. In November 2021, the Biden-Harris administration increased oversight of prescription [Read More]
As more technology-driven solutions disrupt the traditional healthcare model, many plan sponsors are moving away from the turn-key approach offered by insurance carriers. Before making such a decision, plan sponsors should determine if they are ready to take on the fiduciary challenges associated with this move.
The Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 is a federal law that prevents group health plans and health issuers that provide mental health and/or substance use benefits from imposing less [Read More]
The Departments of Health and Human Services, Labor, and Treasury issued guidance that health plans, including employer-sponsored group health plans, must cover the costs of certain at-home COVID-19 tests purchased on or after January 15, 2022.
The administrative complexities of the healthcare system and its onerous regulatory environment continue to increase the cost to administer a self-funded health plan – not to mention exacerbating the operating and compliance risks to plan [Read More]